Analysts on Wall Street project that Energy Transfer LP (ET) will announce quarterly earnings of $0.34 per share in its forthcoming report, representing an increase of 17.2% year over year. Revenues ...

CHICAGO, IL—Two new drugs targeting lipoprotein(a)—one a small interfering RNA (siRNA), the other an oral agent that prevents its formation—both showed positive results in early phase II studies, with ...

Louisiana-Pacific Corporation, a leading manufacturer of high-performance building products, today reported its financial results for the fourth quarter and year ended December 31, 2024. Siding net ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biotechnology company using artificial intelligence and genomics to transform oncology drug development, announced additional details and clinical ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...

JUNO BEACH, Fla., Oct. 21, 2025 /PRNewswire/ -- XPLR Infrastructure, LP (NYSE: XIFR) today announced that it plans to report third-quarter 2025 financial results after the close of the New York Stock ...

CHICAGO — The remarkable and sustained reductions in lipoprotein(a) ( Lp[a]) achieved with lepodisiran (Eli Lilly) , a novel small-interfering (si)RNA molecule, in a phase 2 trial might signal a major ...